Abstract:Until now, observational studies have explored the impact of vitamin C intake on Alzheimer’s disease (AD) risk, however, reported ambiguous findings. To develop effective therapies or prevention, the causal link between vitamin C levels and AD should be established. Here, we selected 11 plasma vitamin C genetic variants from a large-scale plasma vitamin C GWAS dataset (N = 52,018) as the potential instrumental variables. We extracted their corresponding summary statistics from large-scale IGAP clinically diagnosed AD GWAS dataset (N = 63,926) and UK Biobank AD proxy phenotype GWAS dataset (N = 314,278), as well as two UK Biobank subgroups including the maternal AD group (27,696 cases of maternal AD and 260,980 controls) and paternal AD group (14,338 cases of paternal AD and 245,941 controls). We then performed a Mendelian randomization (MR) study to evaluate the causal association between plasma vitamin C levels and the risk of AD and AD proxy phenotype. Meanwhile, we further verified these findings using a large-scale cognitive performance GWAS dataset (N = 257,841). In IGAP, we found no significant causal association between plasma vitamin C levels and the risk of AD. In UK Biobank, we found that per 1 SD increase in plasma vitamin C levels (about 20.2 μmol/l) was significantly associated with the reduced risk of AD proxy phenotype (OR = 0.93, 95% CI 0.88–0.98, P = 7.00E−03). A subgroup MR analysis in UK Biobank indicated that per 1 SD increase in plasma vitamin C levels could significantly reduce the risk of AD proxy phenotype in the maternal AD group (OR = 0.89, 95% CI 0.84–0.94, P = 7.29E−05), but not in the paternal AD group (OR = 1.02, 95% CI 0.92–1.12, P = 7.59E−01). The leave-one-out permutation further showed that the SLC23A1 rs33972313 variant largely changed the precision of the overall MR estimates in all these four GWAS datasets. Meanwhile, we did not observe any significant causal effect of plasma vitamin C levels on the cognitive performance. We demonstrated that there may be no causal association between plasma vitamin C levels and the risk of AD in people of European descent. The insistent findings in clinically diagnosed AD and AD proxy phenotype may be caused by the phenotypic heterogeneity.

Causal Effects of Plasma Haptoglobin Levels on Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.

Effects of Homocysteine on Nonalcoholic Fatty Liver Related Disease: A Mendelian Randomization Study

The Impact of Homocysteine on the Risk of Coronary Artery Diseases in Individuals with Diabetes: a Mendelian Randomization Study

The Impact of Plasma Vitamin C Levels on the Risk of Cardiovascular Diseases and Alzheimer's Disease: A Mendelian Randomization Study.

Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study.

Mendelian Randomization to Evaluate the Effect of Plasma Vitamin C Levels on the Risk of Alzheimer’s Disease

Causal association between adiponectin and the risk of Alzheimer's disease: A Mendelian randomization study

A Mendelian Randomization Study of Plasma Homocysteine Levels and Cerebrovascular and Neurodegenerative Diseases

Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study

No Causal Effects Of Plasma Homocysteine Levels On The Risk Of Coronary Heart Disease Or Acute Myocardial Infarction: A Mendelian Randomization Study

Association Between Plasma Brain-derived Neurotrophic Factor Level and Alzheimer's Disease: A Mendelian Randomization Study.

Causal relationship between circulating immune cells and the risk of Alzheimer's disease: A Mendelian randomization study

No Causal Association Between Plasma Homocysteine Levels and Atrial Fibrillation: A Mendelian Randomization Study

Investigating Causal Relations Between Circulating Metabolites and Alzheimer’s Diseases: A Mendelian Randomization Study

Causal effects of plasma metabolites on autoimmune hepatitis (AIH): a bidirectional two-sample mendelian randomization study

Association between plasma brain-derived neurotrophic factor level and Alzheimer’s disease: a Mendelian randomization study

Cathepsin in Alzheimer's Disease, Parkinson's Disease and Dementia with Lewy Bodies: Mendelian Randomization Study

Appraising the Causal Association of Plasma Homocysteine Levels With Atrial Fibrillation Risk: A Two-Sample Mendelian Randomization Study

Genetic Insights into the Association and Causality Between Blood Metabolites and Alzheimer's Disease

Circulating biomarkers of immunity and inflammation, risk of Alzheimer’s disease, and hippocampal volume: a Mendelian randomization study

Causal relationships between peripheral immune cells and Alzheimer’s disease: a two-sample Mendelian randomization study